Open AccessPotentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
Author(s) -
David J. Gladstone,
Esther Bui,
Jiming Fang,
Andreas Laupacis,
M. Patrice Lindsay,
Jack V. Tu,
Frank L. Silver,
Moira K. Kapral
Publication year - 2008
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.516344
Subject(s) - medicine , atrial fibrillation , warfarin , stroke (engine) , antithrombotic , prospective cohort study , cardiology , emergency medicine , mechanical engineering , engineering
Warfarin is the most effective stroke prevention medication for high-risk individuals with atrial fibrillation, yet it is often underused. This study examined the magnitude of this problem in a large contemporary, prospective stroke registry.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom